GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) » Definitions » ROCE %

PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) ROCE % : 0.00% (As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is PT Diagnos Laboratorium Utama Tbk ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. PT Diagnos Laboratorium Utama Tbk's annualized ROCE % for the quarter that ended in . 20 was 0.00%.


PT Diagnos Laboratorium Utama Tbk ROCE % Historical Data

The historical data trend for PT Diagnos Laboratorium Utama Tbk's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Diagnos Laboratorium Utama Tbk ROCE % Chart

PT Diagnos Laboratorium Utama Tbk Annual Data
Trend
ROCE %

PT Diagnos Laboratorium Utama Tbk Semi-Annual Data
ROCE %

PT Diagnos Laboratorium Utama Tbk ROCE % Calculation

PT Diagnos Laboratorium Utama Tbk's annualized ROCE % for the fiscal year that ended in . 20 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=/( ( ( - ) + ( - ) )/ )
=/( (+)/ )
=/
= %

PT Diagnos Laboratorium Utama Tbk's ROCE % of for the quarter that ended in . 20 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=/( ( ( - ) + ( - ) )/ )
=/( ( + )/ )
=/
= %

(1) Note: The EBIT data used here is one times the annual (. 20) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Diagnos Laboratorium Utama Tbk  (ISX:DGNS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


PT Diagnos Laboratorium Utama Tbk ROCE % Related Terms

Thank you for viewing the detailed overview of PT Diagnos Laboratorium Utama Tbk's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Diagnos Laboratorium Utama Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan Teuku Cik Ditiro 1 No. 11 A, B, C, Gedung Graha Anam, 2nd Floor, Kelurahan Gondangdia, Kecamatan Menteng, Jakarta Pusat, Jakarta, IDN, 10350
PT Diagnos Laboratorium Utama Tbk provides laboratory services that include health support service activities that are managed by both the government and the private sector, such as health laboratories. The business products and services include Clinical Pathology Laboratory, Anatomy Pathology Laboratory, Genomic Laboratory, Homecare Health Services, and Corporate Health Service.

PT Diagnos Laboratorium Utama Tbk Headlines

From GuruFocus

Cvent CEO & Founder to Present at Water Tower Research Fireside Chat

By Business Wire Business Wire 11-12-2021

Cvent Announces New Independent Board Members for Post-Merger Company

By Business Wire Business Wire 12-01-2021

Cvent and Dragoneer to Present at Water Tower Research Fireside Chat

By Business Wire Business Wire 11-29-2021